Genetic Testing Improves Care for Children with Neurodevelopmental Disorders
Genetic Testing Revolutionizes Care for Children wiht Neurodevelopmental Disorders
Los Angeles, CA – A groundbreaking study from UCLA Health reveals that integrating genetic testing into the care of children with neurodevelopmental disorders (NDD) like autism and global growth delay leads to more personalized and effective treatment. The research, published in Genetics in Medicine, highlights the transformative impact of this approach on patient outcomes.
“children with neurodevelopmental differences often face complex medical needs,and traditional referral pathways can lead to delays in diagnosis and intervention,” explains Dr. Julian Martinez, a medical geneticist at UCLA Health and senior co-author of the study. “Our UCLA Care and Research in NeuroGenetics (CARING) Clinic addresses this gap by bringing together a team of specialists – a psychiatrist, geneticist, neurologist, and psychologist – to provide complete care under one roof.”
The study analyzed medical records of 316 patients treated at the CARING Clinic between 2014 and 2019. Of the 246 patients who underwent genetic testing, a remarkable 42% received a diagnosis of a rare genetic condition or strong indication of one.This genetic insight directly influenced treatment plans,leading to:
Medication changes: 14% of patients experienced adjustments to their medication regimens based on their genetic profile.
Clinical trial referrals: 3% of patients were referred to participate in clinical trials specifically tailored to their genetic condition.
* Enhanced medical surveillance: 30% of patients benefited from modified monitoring for potential health issues associated with their genetic diagnosis.
Furthermore,genetic testing prompted specialty referrals for 70% of patients,with cardiac and gastrointestinal issues emerging as the most common concerns.
“This research underscores the profound impact of a genetics-informed approach to neuropsychiatric care,” says Dr.Aaron Besterman, former UCLA Health Postdoctoral Researcher and senior author of the study, now at Rady Children’s Institute for Genomic Medicine. “As personalized medicine advances, integrating genetic expertise with specialized psychiatric and neurological care will be crucial for delivering truly comprehensive care. We hope our model serves as a blueprint for healthcare systems adapting to these evolving needs.”
Dr. Martinez emphasizes the importance of early genetic testing, stating, “Early testing truly transforms the care a patient receives. Genomic medicine should be a cornerstone of clinician training to ensure timely and effective interventions for children with NDDs.”
Genetic Testing: A Game Changer for Children with Neurodevelopmental Disorders
NewsDirectory3.com Exclusive Interview with Dr. Julian Martinez
NewsDirectory3: Dr. Martinez, your recent study published in Genetics in Medicine highlights the transformative role of genetic testing in helping children with neurodevelopmental disorders (NDDs). Can you elaborate on this approach and its impact?
Dr. martinez: Absolutely. Children with NDDs like autism and global growth delay often face complex medical needs.conventional referral pathways can be lengthy, leading to delays in diagnosis and treatment. Our UCLA care and Research in NeuroGenetics (CARING) Clinic takes a different approach. We bring together a multidisciplinary team – psychiatrist, geneticist, neurologist, and psychologist – to provide comprehensive care under one roof.
NewsDirectory3: How does genetic testing specifically contribute to this comprehensive care?
Dr. Martinez: We’ve found that integrating genetic testing is crucial. our study analyzed data from 316 patients at the CARING Clinic, and of those who underwent genetic testing, 42% received a diagnosis of a rare genetic condition or a strong indication of one. This genetic insight directly informs treatment decisions.
NewsDirectory3: can you give some examples of how genetic findings influence treatment?
Dr. Martinez: Absolutely. We saw medication changes in 14% of patients due to their genetic profile. Three percent were referred to clinical trials tailored to their specific genetic condition, and 30% benefited from modified medical monitoring for potential health issues linked to their diagnosis.Importantly, genetic testing also prompted specialty referrals for 70% of patients, with cardiac and gastrointestinal concerns emerging as common issues.
NewsDirectory3: Your findings suggest a paradigm shift in how we approach ndds.What’s your message to healthcare providers and policymakers?
Dr. Martinez: Early genetic testing should be a cornerstone of care for children with NDDs. It truly transforms the care they receive. We encourage continued clinician training in genomic medicine to ensure timely and effective interventions. Our CARING Clinic model demonstrates how multidisciplinary, genetics-informed care can make a real difference in the lives of these children.